Serum-Soluble Tumor Necrosis Factor Receptor 2 (sTNF-R2) Level Determines Clinical Outcome in Patients with Aggressive Non-Hodgkin's Lymphoma.
Author:
Hisashi Tsurumi,Naoe Goto,Masao Takemura,Takeshi Hara,Michio Sawada,Toshiki Yamada,Senji Kasahara,Nobuhiro Kanemura,Takeshi Takahashi,Masami Oyama,Eiichi Tomita,Tsuyoshi Takami,Hisataka Moriwaki
Copyright © 2004 American Society of Hematology